Can african hospitals follow the rules for treating childhood kidney cancer?

NCT ID NCT04423484

Recruiting now Knowledge-focused Sponsor: French Africa Pediatric Oncology Group Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how well hospitals in Africa follow recommended treatment steps for children with a type of kidney cancer called nephroblastoma. Researchers will check if doctors correctly diagnose the disease, give the right treatments, and track how children recover. The goal is to find gaps in care and help improve survival for these children.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEPHROBLASTOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Wilms tumor Wilms tumor 1

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NEPHROBLASTOMA

Contacts and locations

Locations

CHU Gabriel Touré (HGT)
RECRUITING

Bamako, Mali
CHU de Treichville à ABIDJAN
RECRUITING

Abidjan, Abidjan Autonomous District, Côte d’Ivoire
CUK (Cliniques Universitaires de Kinshasa)
RECRUITING

Kinshasa, BP 12 KIN XI, Democratic Republic of the Congo
Centre Hospitalier Universitaire Pédiatrique Charles De Gaulle
RECRUITING

Ouagadougou, Burkina Faso
Cliniques Universitaires de Lubumbashi (CUL)
RECRUITING

Lubumbashi, BP 1825, Democratic Republic of the Congo
HJRA, Hôpital universitaire Joseph Ravoahangy Andrianavalona
RECRUITING

Antananarivo, Madagascar
Hôpital Aristide Le Dantec, Avenue Pasteur, BP 3001
RECRUITING

Dakar, Dakar, Senegal

More trials for these conditions

Other studies related to the condition(s) this trial covers.